Stockreport

Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria

Titan Pharmaceuticals, Inc.  (TTNP) 
NASDAQ:AMEX Investor Relations: ir.titanpharm.com
PDF SOUTH SAN FRANCISCO, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that by letter dat [Read more]